XBiotech Announces First Patient Enrolled in Randomized Multi-Center Clinical Study Evaluating Bermekimab Therapy in Patients with Hidradenitis Suppurativa

Press/Media

Period	29 Oct 2019

Media coverage

Title	XBiotech Announces First Patient Enrolled in Randomized Multi-Center Clinical Study Evaluating Bermekimab Therapy in Patients with Hidradenitis Suppurativa
Media name/outlet	PharmiWeb
Country/Territory	United Kingdom
Date	29/10/19
URL	https://www.pharmiweb.com/press-release/2019-10-29/xbiotech-announces-first-patient-enrolled-in-randomized-multi-center-clinical-study-evaluating-bermekimab-therapy-in-patients-with-hidradenitis-suppur
Persons	Alice Gottlieb